LOSARTAN

LOSARTAN was reported 177626 times

These side effects are most commonly reported by patients taking LOSARTAN:

# Side effect Count
0 FATIGUE 12774
1 DIARRHOEA 10679
2 NAUSEA 9917
3 DRUG INEFFECTIVE 9903
4 DYSPNOEA 9031
5 DIZZINESS 8618
6 HEADACHE 8579
7 PAIN 7830
8 OFF LABEL USE 7807
9 ARTHRALGIA 6762
10 MALAISE 6244
11 ASTHENIA 6190
12 COUGH 5853
13 VOMITING 5623
14 FALL 5559
15 PRURITUS 5361
16 PAIN IN EXTREMITY 4997
17 HYPERTENSION 4985
18 DEATH 4980
19 RASH 4928
20 WEIGHT DECREASED 4825
21 ACUTE KIDNEY INJURY 4768
22 PNEUMONIA 4445
23 BLOOD PRESSURE INCREASED 4319
24 BACK PAIN 4226
25 CHRONIC KIDNEY DISEASE 4198
26 PERIPHERAL SWELLING 4031
27 DECREASED APPETITE 3954
28 PRODUCT DOSE OMISSION ISSUE 3944
29 INSOMNIA 3939
30 CONSTIPATION 3913
31 FEELING ABNORMAL 3662
32 ABDOMINAL PAIN UPPER 3609
33 PYREXIA 3562
34 GAIT DISTURBANCE 3502
35 ANXIETY 3479
36 URINARY TRACT INFECTION 3345
37 CHEST PAIN 3299
38 HYPOTENSION 3243
39 COVID-19 3209
40 MUSCLE SPASMS 3081
41 RENAL FAILURE 3072
42 ABDOMINAL DISCOMFORT 3035
43 ALOPECIA 2946
44 CONDITION AGGRAVATED 2909
45 BLOOD GLUCOSE INCREASED 2860
46 WEIGHT INCREASED 2786
47 ABDOMINAL PAIN 2731
48 DEPRESSION 2586
49 MYALGIA 2573
50 ANAEMIA 2497
51 MEMORY IMPAIRMENT 2434
52 DEHYDRATION 2372
53 DRUG INTERACTION 2372
54 NASOPHARYNGITIS 2297
55 SOMNOLENCE 2290
56 PRODUCT USE IN UNAPPROVED INDICATION 2248
57 VISUAL IMPAIRMENT 2181
58 MYOCARDIAL INFARCTION 2176
59 CONFUSIONAL STATE 2134
60 MUSCULAR WEAKNESS 2129
61 INJECTION SITE PAIN 2121
62 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2065
63 CEREBROVASCULAR ACCIDENT 2057
64 TREMOR 2056
65 VISION BLURRED 2035
66 PARAESTHESIA 2001
67 HYPOAESTHESIA 1986
68 PALPITATIONS 1943
69 INFLUENZA 1931
70 HYPERHIDROSIS 1926
71 HYPERSENSITIVITY 1902
72 ERYTHEMA 1888
73 ATRIAL FIBRILLATION 1867
74 JOINT SWELLING 1853
75 PRODUCT USE ISSUE 1773
76 DRUG HYPERSENSITIVITY 1758
77 DRY SKIN 1738
78 INCORRECT DOSE ADMINISTERED 1727
79 HEART RATE INCREASED 1705
80 OEDEMA PERIPHERAL 1676
81 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1662
82 CONTUSION 1612
83 GASTROOESOPHAGEAL REFLUX DISEASE 1606
84 PSORIASIS 1606
85 DYSPEPSIA 1600
86 BALANCE DISORDER 1575
87 SYNCOPE 1560
88 HAEMOGLOBIN DECREASED 1553
89 PLATELET COUNT DECREASED 1549
90 ABDOMINAL DISTENSION 1538
91 LOSS OF CONSCIOUSNESS 1538
92 NEUROPATHY PERIPHERAL 1506
93 SINUSITIS 1504
94 INFECTION 1456
95 ARTHRITIS 1451
96 ASTHMA 1449
97 DRY MOUTH 1449
98 ILLNESS 1443
99 RENAL IMPAIRMENT 1439
100 URTICARIA 1432
101 DRUG DOSE OMISSION 1423
102 OROPHARYNGEAL PAIN 1419
103 SWELLING 1410
104 CHEST DISCOMFORT 1387
105 HALLUCINATION 1374
106 INTENTIONAL PRODUCT MISUSE 1367
107 EYE PAIN 1348
108 DIABETES MELLITUS 1346
109 CARDIAC FAILURE CONGESTIVE 1341
110 CHILLS 1323
111 HOT FLUSH 1320
112 CARDIAC DISORDER 1305
113 GASTROINTESTINAL HAEMORRHAGE 1302
114 WHITE BLOOD CELL COUNT DECREASED 1302
115 EPISTAXIS 1298
116 BRONCHITIS 1279
117 CATARACT 1272
118 END STAGE RENAL DISEASE 1265
119 BLOOD CREATININE INCREASED 1241
120 INTENTIONAL PRODUCT USE ISSUE 1227
121 SEPSIS 1203
122 DYSPHONIA 1200
123 BLOOD PRESSURE DECREASED 1199
124 TOXICITY TO VARIOUS AGENTS 1155
125 DYSPHAGIA 1151
126 TACHYCARDIA 1149
127 DYSGEUSIA 1148
128 HOSPITALISATION 1138
129 MUSCULOSKELETAL STIFFNESS 1137
130 CARDIAC FAILURE 1135
131 AMNESIA 1129
132 RHINORRHOEA 1114
133 MIGRAINE 1111
134 THROMBOSIS 1110
135 PRODUCT QUALITY ISSUE 1106
136 RHEUMATOID ARTHRITIS 1083
137 THERAPY INTERRUPTED 1077
138 HYPONATRAEMIA 1074
139 MOBILITY DECREASED 1048
140 SEIZURE 1046
141 EYE IRRITATION 1044
142 BURNING SENSATION 1043
143 SKIN EXFOLIATION 1028
144 ANGIOEDEMA 1026
145 TINNITUS 998
146 FLATULENCE 996
147 SLEEP DISORDER 989
148 COMPLETED SUICIDE 982
149 OSTEOARTHRITIS 978
150 GASTROINTESTINAL DISORDER 977
151 HAEMORRHAGE 973
152 HYPERKALAEMIA 950
153 DRUG INTOLERANCE 942
154 NASAL CONGESTION 937
155 PRODUCTIVE COUGH 936
156 RENAL INJURY 930
157 FLUSHING 928
158 BONE PAIN 926
159 FLUID RETENTION 915
160 SWELLING FACE 915
161 DISEASE PROGRESSION 903
162 WHEEZING 888
163 PRODUCT SUBSTITUTION ISSUE 886
164 STRESS 885
165 PRODUCT DOSE OMISSION 883
166 SKIN DISCOLOURATION 883
167 PULMONARY OEDEMA 882
168 ADVERSE DRUG REACTION 881
169 STOMATITIS 881
170 NECK PAIN 880
171 RENAL DISORDER 877
172 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 874
173 TRANSIENT ISCHAEMIC ATTACK 866
174 POLLAKIURIA 850
175 DRY EYE 848
176 GENERAL PHYSICAL HEALTH DETERIORATION 844
177 BLINDNESS 834
178 EYE PRURITUS 824
179 OXYGEN SATURATION DECREASED 815
180 BLOOD CHOLESTEROL INCREASED 798
181 DEPRESSED MOOD 793
182 LIP SWELLING 793
183 NO ADVERSE EVENT 791
184 PULMONARY EMBOLISM 790
185 DISTURBANCE IN ATTENTION 787
186 FEELING HOT 782
187 DISEASE RECURRENCE 773
188 BLISTER 772
189 VERTIGO 771
190 NERVOUSNESS 769
191 CARDIAC ARREST 764
192 HYPOGLYCAEMIA 763
193 PLEURAL EFFUSION 763
194 COGNITIVE DISORDER 759
195 DISCOMFORT 753
196 RESPIRATORY FAILURE 748
197 NEPHROLITHIASIS 743
198 UNEVALUABLE EVENT 741
199 LETHARGY 739
200 RASH PRURITIC 736
201 DYSPNOEA EXERTIONAL 734
202 EMOTIONAL DISTRESS 729
203 INFLUENZA LIKE ILLNESS 729
204 MUSCULOSKELETAL PAIN 729
205 THROAT IRRITATION 726
206 ARTHROPATHY 724
207 INJECTION SITE ERYTHEMA 723
208 INFLAMMATION 717
209 BLOOD POTASSIUM DECREASED 715
210 HERPES ZOSTER 715
211 THROMBOCYTOPENIA 713
212 OEDEMA 705
213 CELLULITIS 698
214 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 694
215 OCULAR HYPERAEMIA 693
216 ARRHYTHMIA 686
217 SPEECH DISORDER 681
218 NEUTROPENIA 678
219 OVERDOSE 676
220 THERAPY CESSATION 674
221 HYPOKALAEMIA 671
222 BRADYCARDIA 668
223 DIPLOPIA 668
224 UPPER RESPIRATORY TRACT INFECTION 668
225 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 662
226 HEART RATE DECREASED 652
227 NEPHROGENIC ANAEMIA 651
228 GAIT INABILITY 640
229 LUNG DISORDER 638
230 BLOOD GLUCOSE DECREASED 630
231 SURGERY 629
232 UNDERDOSE 626
233 DEVICE ISSUE 625
234 HEPATIC ENZYME INCREASED 621
235 BLOOD PRESSURE ABNORMAL 620
236 HYPERGLYCAEMIA 619
237 MALIGNANT NEOPLASM PROGRESSION 619
238 ACUTE MYOCARDIAL INFARCTION 616
239 HYPOACUSIS 615
240 LACTIC ACIDOSIS 614
241 DYSURIA 610
242 BLOOD PRESSURE FLUCTUATION 608
243 OSTEOPOROSIS 606
244 ADVERSE EVENT 604
245 RECTAL HAEMORRHAGE 603
246 INJECTION SITE BRUISING 596
247 AGITATION 592
248 INJECTION SITE HAEMORRHAGE 588
249 DYSSTASIA 582
250 HAEMATOCHEZIA 578
251 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 575
252 DEEP VEIN THROMBOSIS 572
253 INJECTION SITE PRURITUS 558
254 LIMB DISCOMFORT 555
255 LACRIMATION INCREASED 554
256 MUSCLE TWITCHING 546
257 EYE SWELLING 543
258 TREATMENT NONCOMPLIANCE 543
259 PAIN OF SKIN 541
260 CONTRAINDICATED PRODUCT ADMINISTERED 535
261 TUBULOINTERSTITIAL NEPHRITIS 534
262 AGEUSIA 528
263 ANOSMIA 526
264 LIMB INJURY 525
265 HAEMATURIA 522
266 HEAD INJURY 521
267 RED BLOOD CELL COUNT DECREASED 520
268 INTENTIONAL DOSE OMISSION 517
269 URINARY INCONTINENCE 512
270 NEOPLASM MALIGNANT 510
271 PSORIATIC ARTHROPATHY 509
272 RASH MACULAR 508
273 CYSTITIS 507
274 ORAL PAIN 506
275 THERAPEUTIC RESPONSE UNEXPECTED 506
276 VENTRICULAR TACHYCARDIA 506
277 CHOLELITHIASIS 504
278 GASTRITIS 503
279 LIVER DISORDER 500
280 WHITE BLOOD CELL COUNT INCREASED 497
281 PANCREATITIS 490
282 DEVICE MALFUNCTION 486
283 THERAPEUTIC PRODUCT EFFECT DECREASED 485
284 ALANINE AMINOTRANSFERASE INCREASED 483
285 SUICIDAL IDEATION 483
286 RASH ERYTHEMATOUS 481
287 CARDIO-RESPIRATORY ARREST 479
288 PRODUCT DOSE OMISSION IN ERROR 477
289 HEPATIC STEATOSIS 473
290 DIVERTICULITIS 465
291 EYE DISORDER 465
292 DISORIENTATION 464
293 DERMATITIS ATOPIC 462
294 FACIAL PAIN 461
295 VASCULITIS 460
296 THERAPY NON-RESPONDER 459
297 INJECTION SITE SWELLING 457
298 RASH PAPULAR 457
299 TASTE DISORDER 457
300 ACCIDENTAL EXPOSURE TO PRODUCT 456
301 SWOLLEN TONGUE 456
302 ILL-DEFINED DISORDER 452
303 FEELING COLD 451
304 GOUT 450
305 IMPAIRED GASTRIC EMPTYING 450
306 ECZEMA 445
307 GASTRIC DISORDER 445
308 MULTIPLE SCLEROSIS RELAPSE 441
309 MEDICATION ERROR 439
310 BLOOD SODIUM DECREASED 436
311 SLEEP APNOEA SYNDROME 434
312 ASPARTATE AMINOTRANSFERASE INCREASED 433
313 INFUSION RELATED REACTION 433
314 MOVEMENT DISORDER 433
315 VIRAL INFECTION 431
316 HIP FRACTURE 429
317 HYPOPHAGIA 429
318 SUBARACHNOID HAEMORRHAGE 429
319 WOUND 428
320 DYSKINESIA 427
321 RHABDOMYOLYSIS 427
322 PERICARDIAL EFFUSION 424
323 SKIN DISORDER 421
324 ANGINA PECTORIS 420
325 DYSARTHRIA 419
326 THYROID DISORDER 417
327 PERICARDITIS 416
328 ROAD TRAFFIC ACCIDENT 416
329 URINARY RETENTION 415
330 NIGHTMARE 413
331 THERAPEUTIC RESPONSE DECREASED 413
332 TENSION HEADACHE 412
333 CAROTID ARTERY OCCLUSION 411
334 INTESTINAL OBSTRUCTION 411
335 BREAST CANCER 410
336 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 410
337 GLYCOSYLATED HAEMOGLOBIN INCREASED 408
338 IRRITABILITY 407
339 SKIN ULCER 407
340 COLITIS 404
341 EYE HAEMORRHAGE 404
342 LABORATORY TEST ABNORMAL 404
343 FULL BLOOD COUNT DECREASED 403
344 SKIN LESION 401
345 HYPOXIA 398
346 EATING DISORDER 397
347 ACNE 393
348 FAECES DISCOLOURED 393
349 HEART RATE IRREGULAR 393
350 SNEEZING 389
351 BODY HEIGHT DECREASED 388
352 INTERVERTEBRAL DISC PROTRUSION 388
353 METABOLIC ACIDOSIS 388
354 NEURALGIA 388
355 FUNGAL INFECTION 382
356 HAEMATOMA 382
357 PRURITUS GENITAL 382
358 DEAFNESS 381
359 CEREBRAL HAEMORRHAGE 376
360 PRODUCT AVAILABILITY ISSUE 376
361 RENAL FAILURE ACUTE 376
362 GLOMERULAR FILTRATION RATE DECREASED 375
363 GLAUCOMA 374
364 HYPERSOMNIA 373
365 IMPAIRED HEALING 373
366 PROTEINURIA 373
367 SEASONAL ALLERGY 373
368 JOINT INJURY 372
369 NIGHT SWEATS 370
370 FEEDING DISORDER 369
371 SINUS DISORDER 367
372 HYPERPARATHYROIDISM SECONDARY 364
373 HYPOTHYROIDISM 364
374 SLEEP TERROR 363
375 HAEMOPTYSIS 362
376 HEAD DISCOMFORT 362
377 ANHEDONIA 361
378 DRUG-INDUCED LIVER INJURY 361
379 LOCALISED INFECTION 361
380 BLOOD URINE PRESENT 360
381 CORONARY ARTERY DISEASE 357
382 INJECTION SITE MASS 354
383 BLOOD POTASSIUM INCREASED 353
384 ATRIAL TACHYCARDIA 352
385 INTENTIONAL OVERDOSE 352
386 PAIN IN JAW 351
387 RETCHING 351
388 PLASMA CELL MYELOMA 350
389 INTERNATIONAL NORMALISED RATIO INCREASED 348
390 TYPE 2 DIABETES MELLITUS 346
391 ANAPHYLACTIC REACTION 345
392 CROHN^S DISEASE 344
393 CARDIOSPASM 343
394 CHROMATURIA 342
395 HAIR COLOUR CHANGES 342
396 DRUG EFFECT DECREASED 340
397 REBOUND ACID HYPERSECRETION 339
398 PALMOPLANTAR KERATODERMA 337
399 RESPIRATORY TRACT INFECTION 337
400 LYMPHADENOPATHY 336
401 CHOKING 335
402 SEPTIC SHOCK 335
403 ACUTE RESPIRATORY FAILURE 334
404 INJECTION SITE REACTION 334
405 TOOTH DISORDER 334
406 ERECTILE DYSFUNCTION 333
407 SKIN FISSURES 333
408 POOR QUALITY SLEEP 331
409 CORONARY ARTERY OCCLUSION 330
410 EAR INFECTION 329
411 JOINT STIFFNESS 329
412 RESTLESSNESS 327
413 APHASIA 326
414 HYPERTENSIVE CRISIS 326
415 IMMUNODEFICIENCY 326
416 PRESYNCOPE 326
417 VISUAL ACUITY REDUCED 326
418 BLOOD PRESSURE SYSTOLIC INCREASED 324
419 KIDNEY INFECTION 324
420 PANCYTOPENIA 321
421 ELECTROCARDIOGRAM QT PROLONGED 320
422 DRUG DOSE OMISSION BY DEVICE 319
423 HAIR TEXTURE ABNORMAL 319
424 PRODUCT STORAGE ERROR 319
425 DEMENTIA 318
426 SPINAL PAIN 318
427 ORTHOSTATIC HYPOTENSION 316
428 RESPIRATORY DISORDER 316
429 PHOTOPHOBIA 315
430 EAR PAIN 314
431 PROCEDURAL PAIN 314
432 SKIN BURNING SENSATION 314
433 CRYING 312
434 LOWER RESPIRATORY TRACT INFECTION 312
435 UPPER GASTROINTESTINAL HAEMORRHAGE 312
436 FIBROMYALGIA 311
437 BRAIN FOG 310
438 PROSTATIC SPECIFIC ANTIGEN INCREASED 310
439 EXPIRED PRODUCT ADMINISTERED 309
440 HAEMORRHOIDS 309
441 PANCREATITIS ACUTE 308
442 MUSCULOSKELETAL DISCOMFORT 307
443 THROAT TIGHTNESS 306
444 KNEE ARTHROPLASTY 305
445 PULMONARY MASS 304
446 PALLOR 303
447 SCIATICA 303
448 THIRST 303
449 ABASIA 302
450 DRUG EFFECT INCOMPLETE 302
451 INTERSTITIAL LUNG DISEASE 301
452 PULMONARY HYPERTENSION 301
453 ERUCTATION 300
454 RIB FRACTURE 300
455 NEOPLASM PROGRESSION 298
456 PANIC ATTACK 297
457 THERAPEUTIC RESPONSE SHORTENED 297
458 PROSTATE CANCER 295
459 STAPHYLOCOCCAL INFECTION 295
460 FEAR 291
461 HAEMATEMESIS 290
462 HYPOMAGNESAEMIA 290
463 NEUTROPHIL COUNT DECREASED 290
464 DIABETES MELLITUS INADEQUATE CONTROL 289
465 LUNG NEOPLASM MALIGNANT 288
466 SPINAL FRACTURE 288
467 FEBRILE NEUTROPENIA 287
468 DEPRESSED LEVEL OF CONSCIOUSNESS 286
469 PRODUCT PRESCRIBING ERROR 286
470 HAEMATOCRIT DECREASED 284
471 MULTIPLE SCLEROSIS 284
472 SKIN CANCER 284
473 BASAL CELL CARCINOMA 282
474 INJURY 282
475 MENTAL STATUS CHANGES 281
476 PLATELET COUNT INCREASED 279
477 BACK DISORDER 278
478 FREQUENT BOWEL MOVEMENTS 277
479 HERNIA 277
480 NOCTURIA 277
481 BLOOD TRIGLYCERIDES INCREASED 275
482 UPPER LIMB FRACTURE 275
483 OCULAR DISCOMFORT 272
484 WITHDRAWAL SYNDROME 272
485 FEMUR FRACTURE 271
486 FOOT FRACTURE 271
487 TREATMENT FAILURE 271
488 HIATUS HERNIA 270
489 BLINDNESS UNILATERAL 269
490 MUSCULOSKELETAL CHEST PAIN 269
491 ISCHAEMIC STROKE 268
492 PNEUMONITIS 267
493 PRURITUS GENERALISED 267
494 RASH GENERALISED 267
495 DELIRIUM 265
496 DIABETIC KETOACIDOSIS 265
497 MENTAL DISORDER 264
498 TOOTHACHE 264
499 BLOOD GLUCOSE ABNORMAL 263
500 INCREASED APPETITE 263
501 MALNUTRITION 263
502 BLOOD UREA INCREASED 262
503 CLOSTRIDIUM DIFFICILE INFECTION 261
504 ABNORMAL DREAMS 260
505 CARPAL TUNNEL SYNDROME 260
506 MADAROSIS 260
507 PRODUCT ADMINISTRATION ERROR 259
508 VITAMIN D DEFICIENCY 259
509 DIZZINESS POSTURAL 258
510 MUSCULOSKELETAL DISORDER 258
511 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 258
512 IMPAIRED QUALITY OF LIFE 256
513 OSTEOPENIA 256
514 PRESCRIBED UNDERDOSE 256
515 GLOSSODYNIA 254
516 PARKINSON^S DISEASE 253
517 LIVER FUNCTION TEST ABNORMAL 251
518 RESTLESS LEGS SYNDROME 251
519 APHONIA 249
520 HALLUCINATION, VISUAL 249
521 CARDIOMEGALY 248
522 TENDONITIS 248
523 HEPATITIS 246
524 INSURANCE ISSUE 246
525 RESPIRATORY DISTRESS 246
526 RENAL PAIN 245
527 UNRESPONSIVE TO STIMULI 245
528 AGGRESSION 244
529 ANGER 244
530 ROTATOR CUFF SYNDROME 244
531 ARTERIAL OCCLUSIVE DISEASE 243
532 BLOOD IRON DECREASED 243
533 HEPATIC CIRRHOSIS 243
534 PRODUCT TASTE ABNORMAL 242
535 ACCIDENTAL OVERDOSE 241
536 MELAENA 241
537 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 241
538 SKIN HAEMORRHAGE 241
539 HAIR DISORDER 240
540 RESPIRATORY TRACT CONGESTION 239
541 SKIN IRRITATION 239
542 BLOOD MAGNESIUM DECREASED 238
543 EXTRA DOSE ADMINISTERED 238
544 EYE INFECTION 235
545 ENCEPHALOPATHY 234
546 LOWER LIMB FRACTURE 233
547 EMOTIONAL DISORDER 232
548 HYPOCALCAEMIA 232
549 PRODUCT PHYSICAL ISSUE 231
550 BLOOD ALKALINE PHOSPHATASE INCREASED 230
551 GASTROENTERITIS VIRAL 230
552 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 230
553 COLITIS ULCERATIVE 229
554 GALLBLADDER DISORDER 229
555 NEEDLE ISSUE 229
556 SECRETION DISCHARGE 229
557 VAGINAL HAEMORRHAGE 229
558 EJECTION FRACTION DECREASED 228
559 NEPHROPATHY 228
560 INFARCTION 227
561 POST PROCEDURAL COMPLICATION 227
562 CARDIOVASCULAR DISORDER 226
563 MIDDLE INSOMNIA 226
564 SYSTEMIC LUPUS ERYTHEMATOSUS 226
565 DEVICE DELIVERY SYSTEM ISSUE 225
566 GINGIVAL BLEEDING 225
567 BLOOD COUNT ABNORMAL 223
568 BLOOD PRESSURE INADEQUATELY CONTROLLED 223
569 PERIPHERAL COLDNESS 223
570 IMMUNISATION 222
571 BURSITIS 221
572 JAUNDICE 221
573 COMA 220
574 NODULE 220
575 PRODUCT DISPENSING ERROR 220
576 DECREASED ACTIVITY 218
577 DEVICE LEAKAGE 218
578 INCORRECT PRODUCT ADMINISTRATION DURATION 217
579 INJECTION SITE RASH 216
580 GASTRIC ULCER 215
581 MASS 214
582 MOOD ALTERED 214
583 ORAL HERPES 214
584 INCREASED TENDENCY TO BRUISE 213
585 BACTERIAL INFECTION 212
586 IRRITABLE BOWEL SYNDROME 212
587 MOUTH ULCERATION 212
588 NERVE COMPRESSION 212
589 SUICIDE ATTEMPT 212
590 MUSCLE TIGHTNESS 211
591 PSYCHOLOGICAL TRAUMA 211
592 ABNORMAL BEHAVIOUR 210
593 ANKLE FRACTURE 210
594 BONE DISORDER 210
595 DRY THROAT 210
596 HEMIPARESIS 209
597 BLOOD GLUCOSE FLUCTUATION 208
598 PULMONARY FIBROSIS 208
599 BLOOD CREATINE PHOSPHOKINASE INCREASED 207
600 MUSCLE ATROPHY 207
601 RENAL TUBULAR NECROSIS 207
602 ANAL INCONTINENCE 206
603 LEUKOCYTOSIS 206
604 ORAL DISCOMFORT 206
605 PRODUCT USE COMPLAINT 206
606 CEREBRAL INFARCTION 205
607 LIVER FUNCTION TEST INCREASED 205
608 DECREASED IMMUNE RESPONSIVENESS 204
609 PHOTOSENSITIVITY REACTION 203
610 SPINAL DISORDER 203
611 SPINAL OPERATION 203
612 COLD SWEAT 202
613 EYE DISCHARGE 201
614 COAGULOPATHY 200
615 DERMATITIS 199
616 TOOTH INFECTION 199
617 LIVER INJURY 198
618 MENTAL IMPAIRMENT 198
619 TENDON RUPTURE 198
620 UPPER-AIRWAY COUGH SYNDROME 198
621 CANDIDA INFECTION 197
622 MULTIPLE ORGAN DYSFUNCTION SYNDROME 197
623 SINUS CONGESTION 197
624 WRONG TECHNIQUE IN DRUG USAGE PROCESS 197
625 BLOOD BILIRUBIN INCREASED 196
626 ASCITES 195
627 EAR DISCOMFORT 195
628 HYPOKINESIA 195
629 PRODUCT PRESCRIBING ISSUE 195
630 SENSORY DISTURBANCE 195
631 ABDOMINAL PAIN LOWER 194
632 HAEMORRHAGE INTRACRANIAL 193
633 HYPERLIPIDAEMIA 193
634 MACULAR DEGENERATION 193
635 SPLENOMEGALY 193
636 DRUG DEPENDENCE 192
637 LEUKOPENIA 192
638 RESPIRATORY ARREST 192
639 COORDINATION ABNORMAL 191
640 FEELING JITTERY 191
641 INTERNAL HAEMORRHAGE 191
642 PARAESTHESIA ORAL 191
643 SLUGGISHNESS 191
644 BEDRIDDEN 190
645 BLOOD TEST ABNORMAL 190
646 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 189
647 APPLICATION SITE PAIN 188
648 FOOT DEFORMITY 188
649 LOCAL SWELLING 188
650 MOOD SWINGS 188
651 PULMONARY THROMBOSIS 188
652 C-REACTIVE PROTEIN INCREASED 186
653 LIGAMENT SPRAIN 186
654 POST PROCEDURAL HAEMORRHAGE 186
655 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 185
656 HYPERCALCAEMIA 184
657 JOINT RANGE OF MOTION DECREASED 184
658 OBESITY 184
659 OSTEOMYELITIS 184
660 COVID-19 PNEUMONIA 183
661 DRUG WITHDRAWAL SYNDROME 183
662 MICTURITION URGENCY 183
663 APPLICATION SITE PRURITUS 182
664 CONVULSION 182
665 FOETAL EXPOSURE DURING PREGNANCY 182
666 INFUSION SITE PAIN 182
667 TOOTH FRACTURE 181
668 VITREOUS FLOATERS 181
669 WEIGHT FLUCTUATION 181
670 APPLICATION SITE ERYTHEMA 180
671 HYPOAESTHESIA ORAL 180
672 GROIN PAIN 179
673 INTERVERTEBRAL DISC DEGENERATION 179
674 NERVOUS SYSTEM DISORDER 179
675 GENERALISED OEDEMA 178
676 PRODUCT ADMINISTRATION INTERRUPTED 177
677 DELUSION 176
678 DRUG ADMINISTRATION ERROR 176
679 INCONTINENCE 176
680 INCORRECT DRUG ADMINISTRATION DURATION 176
681 METASTASES TO BONE 176
682 SCAB 176
683 EXOSTOSIS 175
684 PULMONARY CONGESTION 175
685 SCRATCH 175
686 SHOCK 174
687 CIRCULATORY COLLAPSE 171
688 FULL BLOOD COUNT ABNORMAL 171
689 HOSPICE CARE 171
690 PETECHIAE 171
691 LOWER GASTROINTESTINAL HAEMORRHAGE 170
692 LUNG INFECTION 169
693 NERVE INJURY 169
694 BODY TEMPERATURE INCREASED 168
695 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 168
696 CONJUNCTIVITIS 168
697 EXPOSURE VIA SKIN CONTACT 168
698 CYST 167
699 DEVICE DIFFICULT TO USE 167
700 ECONOMIC PROBLEM 167
701 IRON DEFICIENCY ANAEMIA 167
702 RHINITIS 167
703 HUNGER 166
704 OROPHARYNGEAL DISCOMFORT 166
705 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 165
706 PRODUCT ADHESION ISSUE 165
707 SCAR 165
708 URINE OUTPUT DECREASED 165
709 CARDIOGENIC SHOCK 164
710 FOREIGN BODY SENSATION IN EYES 164
711 GASTROINTESTINAL PAIN 164
712 VITAMIN D DECREASED 164
713 HEPATIC FUNCTION ABNORMAL 163
714 SUBDURAL HAEMATOMA 163
715 ULCER 163
716 IMMUNE SYSTEM DISORDER 162
717 ORAL MUCOSAL BLISTERING 162
718 PANCREATIC CARCINOMA 162
719 COLON CANCER 161
720 HIP ARTHROPLASTY 161
721 INTRAOCULAR PRESSURE INCREASED 161
722 MALIGNANT MELANOMA 161
723 PNEUMOTHORAX 161
724 PRODUCT DISTRIBUTION ISSUE 161
725 WOUND INFECTION 161
726 ANAPHYLACTIC SHOCK 160
727 INCORRECT DOSE ADMINISTERED BY DEVICE 160
728 MULTIPLE ALLERGIES 160
729 PHARYNGEAL SWELLING 160
730 SARS-COV-2 TEST POSITIVE 160
731 SPINAL OSTEOARTHRITIS 160
732 ACTIVITIES OF DAILY LIVING IMPAIRED 159
733 GLUCOSE TOLERANCE IMPAIRED 159
734 INJECTION SITE NODULE 159
735 PHARYNGEAL OEDEMA 159
736 PNEUMONIA ASPIRATION 159
737 BONE DENSITY DECREASED 158
738 DIABETIC NEUROPATHY 158
739 GASTROENTERITIS 158
740 JOINT DISLOCATION 158
741 PRODUCT SUPPLY ISSUE 158
742 RENAL CYST 158
743 BLOOD CHOLESTEROL ABNORMAL 157
744 DRUG PRESCRIBING ERROR 157
745 ELECTROLYTE IMBALANCE 157
746 NEOPLASM 157
747 PRODUCT ODOUR ABNORMAL 157
748 SKIN LACERATION 157
749 QUALITY OF LIFE DECREASED 156
750 ARTERIOSCLEROSIS 155
751 FLUID OVERLOAD 154
752 HAEMORRHAGIC STROKE 154
753 PRESCRIBED OVERDOSE 154
754 ASTHMATIC CRISIS 153
755 METASTASES TO LIVER 153
756 POLYURIA 153
757 RETINAL DETACHMENT 153
758 THINKING ABNORMAL 153
759 TRANSFUSION 153
760 RECALLED PRODUCT ADMINISTERED 152
761 MENISCUS INJURY 151
762 ANGINA UNSTABLE 150
763 IMPAIRED WORK ABILITY 150
764 INITIAL INSOMNIA 150
765 MITRAL VALVE INCOMPETENCE 150
766 PARALYSIS 150
767 ATRIAL FLUTTER 149
768 BLADDER CANCER 149
769 BLADDER DISORDER 149
770 MUCOSAL INFLAMMATION 149
771 MYOPATHY 149
772 PRE-EXISTING CONDITION IMPROVED 149
773 TRANSAMINASES INCREASED 149
774 ATRIOVENTRICULAR BLOCK 148
775 BRASH SYNDROME 148
776 ASPHYXIA 147
777 EYE INFLAMMATION 147
778 METASTASES TO LUNG 147
779 MULTI-ORGAN DISORDER 147
780 ONYCHOCLASIS 147
781 SMALL INTESTINAL OBSTRUCTION 147
782 HYPERKERATOSIS 146
783 LARYNGITIS 146
784 MOUTH HAEMORRHAGE 146
785 NAIL DISORDER 146
786 DERMATITIS ALLERGIC 145
787 MUSCLE STRAIN 145
788 APATHY 144
789 LYMPHOCYTE COUNT DECREASED 144
790 MYOCLONUS 144
791 POSTOPERATIVE WOUND INFECTION 144
792 TOOTH LOSS 144
793 VENTRICULAR EXTRASYSTOLES 144
794 ACCIDENT 143
795 CARDIOMYOPATHY 143
796 INJECTION SITE URTICARIA 143
797 KNEE OPERATION 142
798 SINUS BRADYCARDIA 142
799 WRIST FRACTURE 142
800 BRONCHOSPASM 141
801 SQUAMOUS CELL CARCINOMA 141
802 DEMENTIA ALZHEIMER^S TYPE 140
803 DERMATITIS CONTACT 140
804 GASTROINTESTINAL INFECTION 140
805 THERAPY CHANGE 140
806 ABSCESS 139
807 DENTAL CARIES 138
808 MOUTH SWELLING 138
809 PHARYNGITIS 138
810 VARICOSE VEIN 138
811 BREAST PAIN 137
812 CHOKING SENSATION 137
813 FLANK PAIN 137
814 INJECTION SITE DISCOLOURATION 137
815 BOWEL MOVEMENT IRREGULARITY 136
816 HEPATIC FAILURE 136
817 ORAL CANDIDIASIS 136
818 POLYP 136
819 TOOTH ABSCESS 135
820 BLOOD CALCIUM DECREASED 134
821 DEVICE RELATED INFECTION 134
822 POST PROCEDURAL INFECTION 134
823 SUSPECTED SUICIDE 134
824 FACIAL PARALYSIS 133
825 RENAL CANCER 133
826 LYMPHOMA 132
827 UROSEPSIS 132
828 CARDIAC MURMUR 131
829 CYANOSIS 131
830 DIALYSIS 131
831 DRUG RESISTANCE 131
832 IMPAIRED DRIVING ABILITY 131
833 LARGE INTESTINE POLYP 131
834 GAMMA-GLUTAMYLTRANSFERASE INCREASED 130
835 TENDERNESS 130
836 TOOTH EXTRACTION 130
837 CONCUSSION 129
838 DEVICE BREAKAGE 129
839 HICCUPS 129
840 BLINDNESS TRANSIENT 128
841 BRONCHIECTASIS 128
842 CARDIAC FLUTTER 128
843 DRUG EFFECT LESS THAN EXPECTED 128
844 OSTEONECROSIS OF JAW 128
845 SEDATION 128
846 SPUTUM DISCOLOURED 127
847 ALTERED STATE OF CONSCIOUSNESS 126
848 CHOLECYSTECTOMY 126
849 DEVICE DISLOCATION 126
850 MATERNAL EXPOSURE DURING PREGNANCY 126
851 TUBERCULOSIS 126
852 EMPHYSEMA 125
853 SEROTONIN SYNDROME 125
854 SKIN INFECTION 125
855 TEMPERATURE INTOLERANCE 125
856 HAEMORRHAGIC ANAEMIA 124
857 LOSS OF EMPLOYMENT 124
858 OSTEONECROSIS 124
859 PSYCHOTIC DISORDER 124
860 TACHYPNOEA 124
861 EXPOSURE DURING PREGNANCY 123
862 SKIN ATROPHY 123
863 STEVENS-JOHNSON SYNDROME 123
864 DIARRHOEA HAEMORRHAGIC 122
865 FAECES SOFT 122
866 GINGIVAL PAIN 122
867 MYOCARDIAL ISCHAEMIA 122
868 ABNORMAL LOSS OF WEIGHT 121
869 STENT PLACEMENT 121
870 YELLOW SKIN 121
871 ANURIA 120
872 CHOLECYSTITIS 120
873 DRUG ERUPTION 120
874 ACUTE HEPATIC FAILURE 119
875 BACK INJURY 119
876 INFUSION SITE ERYTHEMA 119
877 INJECTION SITE WARMTH 119
878 LEFT VENTRICULAR DYSFUNCTION 119
879 ORAL DISORDER 119
880 SWELLING OF EYELID 119
881 ANKYLOSING SPONDYLITIS 118
882 AORTIC ANEURYSM 118
883 ILEUS 118
884 INABILITY TO AFFORD MEDICATION 118
885 SKIN REACTION 118
886 CONCOMITANT DISEASE AGGRAVATED 117
887 DENGUE FEVER 117
888 EXTRASYSTOLES 117
889 GASTRIC HAEMORRHAGE 117
890 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 117
891 DEFAECATION URGENCY 116
892 PELVIC FRACTURE 116
893 PERITONITIS 116
894 BLOOD CALCIUM INCREASED 115
895 DRUG ABUSE 115
896 DRUG LEVEL INCREASED 115
897 FEELING OF DESPAIR 115
898 HALLUCINATION, AUDITORY 115
899 HYPOVOLAEMIA 115
900 INCORRECT ROUTE OF DRUG ADMINISTRATION 115
901 MYASTHENIA GRAVIS 115
902 OBSTRUCTIVE AIRWAYS DISORDER 115
903 OESOPHAGITIS 115
904 THERAPY PARTIAL RESPONDER 115
905 CARDIAC VALVE DISEASE 114
906 CARDIAC PACEMAKER INSERTION 113
907 PRODUCT RESIDUE PRESENT 113
908 ARTERIOSCLEROSIS CORONARY ARTERY 112
909 BLOOD THYROID STIMULATING HORMONE INCREASED 112
910 CARDIAC OPERATION 112
911 DIVERTICULUM 112
912 FACE OEDEMA 112
913 FRACTURE 112
914 HAEMOGLOBIN INCREASED 112
915 INFUSION SITE SWELLING 112
916 PAPULE 112
917 PRODUCT PREPARATION ERROR 112
918 DEVICE USE ERROR 111
919 PLATELET COUNT ABNORMAL 111
920 ABNORMAL FAECES 110
921 DIVERTICULUM INTESTINAL 110
922 OVERWEIGHT 110
923 PARANOIA 110
924 PROTEIN URINE PRESENT 110
925 TOXIC EPIDERMAL NECROLYSIS 110
926 BREAST MASS 109
927 DEVICE USE ISSUE 109
928 HAND FRACTURE 109
929 NASAL DRYNESS 109
930 HEPATOMEGALY 108
931 HEPATOTOXICITY 108
932 RASH MACULO-PAPULAR 108
933 URINE ODOUR ABNORMAL 108
934 WALKING AID USER 108
935 PELVIC PAIN 107
936 PULMONARY ARTERIAL HYPERTENSION 107
937 SKIN SWELLING 107
938 THYROID MASS 107
939 ACUTE RESPIRATORY DISTRESS SYNDROME 106
940 ATRIOVENTRICULAR BLOCK FIRST DEGREE 106
941 EYELID PTOSIS 106
942 PSYCHIATRIC SYMPTOM 106
943 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 105
944 DISCOURAGEMENT 105
945 EPILEPSY 105
946 HAEMOGLOBIN ABNORMAL 105
947 LACERATION 105
948 PRODUCT PACKAGING QUANTITY ISSUE 105
949 LYMPHOEDEMA 104
950 MOTOR DYSFUNCTION 104
951 MUSCLE DISORDER 104
952 RED BLOOD CELL SEDIMENTATION RATE INCREASED 104
953 TROPONIN INCREASED 104
954 ACIDOSIS 103
955 BACTERAEMIA 103
956 DEVICE DEFECTIVE 103
957 HYPERTHYROIDISM 103
958 INJECTION SITE EXTRAVASATION 103
959 PIGMENTATION DISORDER 103
960 TONGUE DISCOMFORT 103
961 ATAXIA 102
962 CATARACT OPERATION 102
963 ELECTROCARDIOGRAM ABNORMAL 102
964 ESSENTIAL HYPERTENSION 102
965 HAIR GROWTH ABNORMAL 102
966 NASAL DISCOMFORT 102
967 PNEUMONIA BACTERIAL 102
968 PURPURA 102
969 SOMNAMBULISM 102
970 ATELECTASIS 101
971 CARDIAC FAILURE ACUTE 101
972 EYELID PAIN 101
973 HYDRONEPHROSIS 101
974 SPINAL STENOSIS 101
975 ARTHROPOD BITE 100
976 HEPATIC CANCER 100
977 INJURY ASSOCIATED WITH DEVICE 100
978 OLIGOHYDRAMNIOS 100
979 TRICUSPID VALVE INCOMPETENCE 100
980 BREAST CANCER FEMALE 99
981 INTENTIONAL UNDERDOSE 99
982 INTERVERTEBRAL DISC DISORDER 99
983 PHOTOPSIA 99
984 PRODUCT COMPLAINT 99
985 SKIN MASS 99
986 TENDON PAIN 99
987 ANEURYSM 98
988 ECCHYMOSIS 98
989 FURUNCLE 98
990 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 98
991 PERIPHERAL VASCULAR DISORDER 98
992 SKIN PLAQUE 98
993 GASTROINTESTINAL HYPOMOTILITY 97
994 HEMIPLEGIA 97
995 HYPERCHOLESTEROLAEMIA 97
996 PROSTATIC DISORDER 97
997 RHINITIS ALLERGIC 97
998 SPRUE-LIKE ENTEROPATHY 97
999 BLOOD DISORDER 96